| Year |
Citation |
Score |
| 2022 |
Fernandez-Parrilla MA, Reyes-Corona D, Flores-Martinez YM, Nadella R, Bannon MJ, Escobedo L, Maldonado-Berny M, Santoyo-Salazar J, Soto-Rojas LO, Luna-Herrera C, Ayala-Davila J, Gonzalez-Barrios JA, Flores G, Gutierrez-Castillo ME, Espadas-Alvarez AJ, et al. Cerebral dopamine neurotrophic factor transfection in dopamine neurons using neurotensin-polyplex nanoparticles reverses 6-hydroxydopamine-induced nigrostriatal neurodegeneration. Neural Regeneration Research. 17: 854-866. PMID 34472486 DOI: 10.4103/1673-5374.321001 |
0.346 |
|
| 2019 |
Saad MH, Rumschlag M, Guerra MH, Savonen CL, Jaster AM, Olson PD, Alazizi A, Luca F, Pique-Regi R, Schmidt CJ, Bannon MJ. Differentially expressed gene networks, biomarkers, long noncoding RNAs, and shared responses with cocaine identified in the midbrains of human opioid abusers. Scientific Reports. 9: 1534. PMID 30733491 DOI: 10.1038/S41598-018-38209-8 |
0.787 |
|
| 2018 |
Saad MH, Savonen CL, Rumschlag M, Todi SV, Schmidt CJ, Bannon MJ. Opioid Deaths: Trends, Biomarkers, and Potential Drug Interactions Revealed by Decision Tree Analyses. Frontiers in Neuroscience. 12: 728. PMID 30405330 DOI: 10.3389/Fnins.2018.00728 |
0.752 |
|
| 2017 |
Miller ML, Ren Y, Szutorisz H, Warren NA, Tessereau C, Egervari G, Mlodnicka A, Kapoor M, Chaarani B, Morris CV, Schumann G, Garavan H, Goate AM, Bannon MJ, et al. Ventral striatal regulation of CREM mediates impulsive action and drug addiction vulnerability. Molecular Psychiatry. PMID 28439100 DOI: 10.1038/Mp.2017.80 |
0.372 |
|
| 2017 |
Espadas-Alvarez AJ, Bannon MJ, Orozco-Barrios CE, Escobedo-Sanchez L, Ayala-Davila J, Reyes-Corona D, Soto-Rodriguez G, Escamilla-Rivera V, De Vizcaya-Ruiz A, Eugenia Gutierrez-Castillo M, Padilla-Viveros A, Martinez-Fong D. Regulation of human GDNF gene expression in nigral dopaminergic neurons using a new doxycycline-regulated NTS-polyplex nanoparticle system. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 28219741 DOI: 10.1016/j.nano.2017.02.006 |
0.412 |
|
| 2015 |
Bannon MJ, Savonen CL, Jia H, Dachet F, Halter SD, Schmidt CJ, Lipovich L, Kapatos G. Identification of long noncoding RNAs dysregulated in the midbrain of human cocaine abusers. Journal of Neurochemistry. 135: 50-9. PMID 26222413 DOI: 10.1111/Jnc.13255 |
0.81 |
|
| 2015 |
Hernandez-Chan NG, Bannon MJ, Orozco-Barrios CE, Escobedo L, Zamudio S, De la Cruz F, Gongora-Alfaro JL, Armendáriz-Borunda J, Reyes-Corona D, Espadas-Alvarez AJ, Flores-Martínez YM, Ayala-Davila J, Hernandez-Gutierrez ME, Pavón L, García-Villegas R, et al. Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease. Journal of Biomedical Science. 22: 59. PMID 26198255 DOI: 10.1186/s12929-015-0166-7 |
0.428 |
|
| 2015 |
Razgado-Hernandez LF, Espadas-Alvarez AJ, Reyna-Velazquez P, Sierra-Sanchez A, Anaya-Martinez V, Jimenez-Estrada I, Bannon MJ, Martinez-Fong D, Aceves-Ruiz J. The transfection of BDNF to dopamine neurons potentiates the effect of dopamine d3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's disease. Plos One. 10: e0117391. PMID 25693197 DOI: 10.1371/journal.pone.0117391 |
0.471 |
|
| 2015 |
Bannon MJ, Savonen CL, Hartley ZJ, Johnson MM, Schmidt CJ. Investigating the potential influence of cause of death and cocaine levels on the differential expression of genes associated with cocaine abuse. Plos One. 10: e0117580. PMID 25658879 DOI: 10.1371/Journal.Pone.0117580 |
0.791 |
|
| 2014 |
Bannon MJ, Johnson MM, Michelhaugh SK, Hartley ZJ, Halter SD, David JA, Kapatos G, Schmidt CJ. A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2191-9. PMID 24642598 DOI: 10.1038/Npp.2014.70 |
0.488 |
|
| 2014 |
Zhou Y, Michelhaugh SK, Schmidt CJ, Liu JS, Bannon MJ, Lin Z. Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects. Addiction Biology. 19: 122-31. PMID 22026501 DOI: 10.1111/j.1369-1600.2011.00391.x |
0.433 |
|
| 2013 |
Anderson SA, Michaelides M, Zarnegar P, Ren Y, Fagergren P, Thanos PK, Wang GJ, Bannon M, Neumaier JF, Keller E, Volkow ND, Hurd YL. Impaired periamygdaloid-cortex prodynorphin is characteristic of opiate addiction and depression. The Journal of Clinical Investigation. 123: 5334-41. PMID 24231353 DOI: 10.1172/Jci70395 |
0.394 |
|
| 2013 |
Jacobs MM, Ökvist A, Horvath M, Keller E, Bannon MJ, Morgello S, Hurd YL. Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels. Molecular Psychiatry. 18: 1205-10. PMID 23044706 DOI: 10.1038/Mp.2012.140 |
0.454 |
|
| 2012 |
Johnson MM, David JA, Michelhaugh SK, Schmidt CJ, Bannon MJ. Increased heat shock protein 70 gene expression in the brains of cocaine-related fatalities may be reflective of postdrug survival and intervention rather than excited delirium. Journal of Forensic Sciences. 57: 1519-23. PMID 22803793 DOI: 10.1111/j.1556-4029.2012.02212.x |
0.386 |
|
| 2012 |
Martinez-Fong D, Bannon MJ, Trudeau LE, Gonzalez-Barrios JA, Arango-Rodriguez ML, Hernandez-Chan NG, Reyes-Corona D, Armendáriz-Borunda J, Navarro-Quiroga I. NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease. Nanomedicine : Nanotechnology, Biology, and Medicine. 8: 1052-69. PMID 22406187 DOI: 10.1016/j.nano.2012.02.009 |
0.325 |
|
| 2011 |
Johnson MM, Michelhaugh SK, Bouhamdan M, Schmidt CJ, Bannon MJ. The Transcription Factor NURR1 Exerts Concentration-Dependent Effects on Target Genes Mediating Distinct Biological Processes. Frontiers in Neuroscience. 5: 135. PMID 22194714 DOI: 10.3389/fnins.2011.00135 |
0.48 |
|
| 2011 |
Michelhaugh SK, Lipovich L, Blythe J, Jia H, Kapatos G, Bannon MJ. Mining Affymetrix microarray data for long non-coding RNAs: altered expression in the nucleus accumbens of heroin abusers. Journal of Neurochemistry. 116: 459-66. PMID 21128942 DOI: 10.1111/J.1471-4159.2010.07126.X |
0.383 |
|
| 2011 |
Okvist A, Fagergren P, Whittard J, Garcia-Osta A, Drakenberg K, Horvath MC, Schmidt CJ, Keller E, Bannon MJ, Hurd YL. Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers. Biological Psychiatry. 69: 245-52. PMID 21126734 DOI: 10.1016/J.Biopsych.2010.09.037 |
0.389 |
|
| 2009 |
Kristiansen LV, Bannon MJ, Meador-Woodruff JH. Expression of transcripts for myelin related genes in postmortem brain from cocaine abusers. Neurochemical Research. 34: 46-54. PMID 18357522 DOI: 10.1007/S11064-008-9655-3 |
0.454 |
|
| 2008 |
Sin M, Michelhaugh SK, Bannon MJ. D1 receptor regulation of preprotachykinin-A gene by extracellular signal-regulated kinase pathway in striatal cultures. Neuroreport. 19: 187-91. PMID 18185106 DOI: 10.1097/Wnr.0B013E3282F35595 |
0.631 |
|
| 2007 |
Wang J, Michelhaugh SK, Bannon MJ. Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells. The European Journal of Neuroscience. 25: 1982-6. PMID 17439486 DOI: 10.1111/j.1460-9568.2007.05460.x |
0.485 |
|
| 2006 |
Gonzalez-Barrios JA, Lindahl M, Bannon MJ, Anaya-MartÃnez V, Flores G, Navarro-Quiroga I, Trudeau LE, Aceves J, Martinez-Arguelles DB, Garcia-Villegas R, Jiménez I, Segovia J, Martinez-Fong D. Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 857-65. PMID 17015039 DOI: 10.1016/J.Ymthe.2006.09.001 |
0.47 |
|
| 2006 |
Arango-Rodriguez ML, Navarro-Quiroga I, Gonzalez-Barrios JA, Martinez-Arguelles DB, Bannon MJ, Kouri J, Forgez P, Rostene W, Garcia-Villegas R, Jimenez I, Martinez-Fong D. Biophysical characteristics of neurotensin polyplex for in vitro and in vivo gene transfection. Biochimica Et Biophysica Acta. 1760: 1009-20. PMID 16730907 DOI: 10.1016/j.bbagen.2006.02.021 |
0.369 |
|
| 2006 |
Albertson DN, Schmidt CJ, Kapatos G, Bannon MJ. Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2304-12. PMID 16710320 DOI: 10.1038/Sj.Npp.1301089 |
0.743 |
|
| 2006 |
Calin-Jageman IE, Wang J, Bannon MJ. Regulation of the preprotachykinin-I gene promoter through a protein kinase A-dependent, cyclic AMP response element-binding protein-independent mechanism. Journal of Neurochemistry. 97: 255-64. PMID 16515544 DOI: 10.1111/j.1471-4159.2006.03738.x |
0.72 |
|
| 2006 |
Bouhamdan M, Yan HD, Yan XH, Bannon MJ, Andrade R. Brain-specific regulator of G-protein signaling 9-2 selectively interacts with alpha-actinin-2 to regulate calcium-dependent inactivation of NMDA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2522-30. PMID 16510730 DOI: 10.1523/JNEUROSCI.4083-05.2006 |
0.303 |
|
| 2005 |
Michelhaugh SK, Vaitkevicius H, Wang J, Bouhamdan M, Krieg AR, Walker JL, Mendiratta V, Bannon MJ. Dopamine neurons express multiple isoforms of the nuclear receptor nurr1 with diminished transcriptional activity. Journal of Neurochemistry. 95: 1342-50. PMID 16313515 DOI: 10.1111/j.1471-4159.2005.03458.x |
0.442 |
|
| 2005 |
Sin M, Walker PD, Bouhamdan M, Quinn JP, Bannon MJ. Preferential expression of an AAV-2 construct in NOS-positive interneurons following intrastriatal injection. Brain Research. Molecular Brain Research. 141: 74-82. PMID 16153741 DOI: 10.1016/J.Molbrainres.2005.08.008 |
0.631 |
|
| 2005 |
Bannon MJ, Kapatos G, Albertson DN. Gene expression profiling in the brains of human cocaine abusers Addiction Biology. 10: 119-126. PMID 15849025 DOI: 10.1080/13556210412331308921 |
0.735 |
|
| 2005 |
Bannon MJ. The dopamine transporter: role in neurotoxicity and human disease. Toxicology and Applied Pharmacology. 204: 355-60. PMID 15845424 DOI: 10.1016/j.taap.2004.08.013 |
0.418 |
|
| 2005 |
Wang J, Bannon MJ. Sp1 and Sp3 activate transcription of the human dopamine transporter gene. Journal of Neurochemistry. 93: 474-82. PMID 15816870 DOI: 10.1111/j.1471-4159.2005.03051.x |
0.447 |
|
| 2004 |
Bouhamdan M, Michelhaugh SK, Calin-Jageman I, Ahern-Djamali S, Bannon MJ. Brain-specific RGS9-2 is localized to the nucleus via its unique proline-rich domain. Biochimica Et Biophysica Acta. 1691: 141-50. PMID 15110994 DOI: 10.1016/j.bbamcr.2004.01.005 |
0.733 |
|
| 2004 |
Bannon MJ, Pruetz B, Barfield E, Schmidt CJ. Transcription factors specifying dopamine phenotype are decreased in cocaine users. Neuroreport. 15: 401-4. PMID 15094491 DOI: 10.1097/00001756-200403010-00003 |
0.491 |
|
| 2004 |
Albertson DN, Pruetz B, Schmidt CJ, Kuhn DM, Kapatos G, Bannon MJ. Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. Journal of Neurochemistry. 88: 1211-9. PMID 15009677 DOI: 10.1046/J.1471-4159.2003.02247.X |
0.73 |
|
| 2002 |
Bannon MJ, Pruetz B, Manning-Bog AB, Whitty CJ, Michelhaugh SK, Sacchetti P, Granneman JG, Mash DC, Schmidt CJ. Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proceedings of the National Academy of Sciences of the United States of America. 99: 6382-5. PMID 11959923 DOI: 10.1073/Pnas.092654299 |
0.795 |
|
| 2001 |
Michelhaugh SK, Fiskerstrand C, Lovejoy E, Bannon MJ, Quinn JP. The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. Journal of Neurochemistry. 79: 1033-8. PMID 11739616 DOI: 10.1046/j.1471-4159.2001.00647.x |
0.491 |
|
| 2001 |
Bannon MJ, Michelhaugh SK, Wang J, Sacchetti P. The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 11: 449-55. PMID 11704422 DOI: 10.1016/S0924-977X(01)00122-5 |
0.724 |
|
| 2001 |
Sacchetti P, Mitchell TR, Granneman JG, Bannon MJ. Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. Journal of Neurochemistry. 76: 1565-72. PMID 11238740 DOI: 10.1046/J.1471-4159.2001.00181.X |
0.742 |
|
| 2000 |
Walker PD, Andrade R, Quinn JP, Bannon MJ. Real-time analysis of preprotachykinin promoter activity in single cortical neurons. Journal of Neurochemistry. 75: 882-5. PMID 10899967 DOI: 10.1046/J.1471-4159.2000.0750882.X |
0.363 |
|
| 1999 |
Sacchetti P, Brownschidle LA, Granneman JG, Bannon MJ. Characterization of the 5'-flanking region of the human dopamine transporter gene. Brain Research. Molecular Brain Research. 74: 167-74. PMID 10640687 DOI: 10.1016/S0169-328X(99)00275-2 |
0.711 |
|
| 1999 |
Hahn MK, Bannon MJ. Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation. Neuroscience. 94: 1183-8. PMID 10625057 DOI: 10.1016/S0306-4522(99)00319-X |
0.691 |
|
| 1999 |
Burchett SA, Bannon MJ, Granneman JG. RGS mRNA expression in rat striatum: modulation by dopamine receptors and effects of repeated amphetamine administration. Journal of Neurochemistry. 72: 1529-33. PMID 10098858 DOI: 10.1046/J.1471-4159.1999.721529.X |
0.463 |
|
| 1998 |
Hahn MK, Bannon MJ. Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus. European Journal of Pharmacology. 348: 155-60. PMID 9652329 DOI: 10.1016/S0014-2999(98)00150-2 |
0.675 |
|
| 1998 |
Burchett SA, Volk ML, Bannon MJ, Granneman JG. Regulators of G protein signaling: rapid changes in mRNA abundance in response to amphetamine. Journal of Neurochemistry. 70: 2216-9. PMID 9572311 DOI: 10.1046/J.1471-4159.1998.70052216.X |
0.397 |
|
| 1997 |
Joyce JN, Smutzer G, Whitty CJ, Myers A, Bannon MJ. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 885-97. PMID 9399211 DOI: 10.1002/Mds.870120609 |
0.607 |
|
| 1997 |
Burchett SA, Bannon MJ. Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration. Brain Research. Molecular Brain Research. 49: 95-102. PMID 9387868 DOI: 10.1016/S0169-328X(97)00131-9 |
0.41 |
|
| 1997 |
Whitty CJ, Paul MA, Bannon MJ. Neurokinin receptor mRNA localization in human midbrain dopamine neurons. The Journal of Comparative Neurology. 382: 394-400. PMID 9183701 DOI: 10.1002/(Sici)1096-9861(19970609)382:3<394::Aid-Cne6>3.0.Co;2-Z |
0.641 |
|
| 1997 |
Bannon MJ, Whitty CJ. Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology. 48: 969-77. PMID 9109886 DOI: 10.1212/Wnl.48.4.969 |
0.652 |
|
| 1996 |
Moody CA, Granneman JG, Bannon MJ. Dopamine transporter binding in rat striatum and nucleus accumbens is unaltered following chronic changes in dopamine levels. Neuroscience Letters. 217: 55-7. PMID 8905738 DOI: 10.1016/0304-3940(96)13048-2 |
0.44 |
|
| 1995 |
Bannon MJ, Whitty CJ. Neurokinin receptor gene expression in substantia nigra: localization, regulation, and potential physiological significance. Canadian Journal of Physiology and Pharmacology. 73: 866-70. PMID 8846423 DOI: 10.1139/Y95-119 |
0.683 |
|
| 1995 |
Bannon MJ, Brownschidle LA, Tian Y, Whitty CJ, Poosch MS, D'sa C, Moody CA. Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamine. Brain Research. 695: 19-24. PMID 8574643 DOI: 10.1016/0006-8993(95)00791-N |
0.665 |
|
| 1995 |
Whitty CJ, Walker PD, Goebel DJ, Poosch MS, Bannon MJ. Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra. Neuroscience. 64: 419-25. PMID 7535403 DOI: 10.1016/0306-4522(94)00373-D |
0.638 |
|
| 1994 |
Tian Y, Kapatos G, Granneman JG, Bannon MJ. Dopamine and gamma-aminobutyric acid transporters: differential regulation by agents that promote phosphorylation. Neuroscience Letters. 173: 143-6. PMID 7936402 DOI: 10.1016/0304-3940(94)90169-4 |
0.323 |
|
| 1994 |
Sanghera MK, Manaye KF, Liang CL, Lacopino AM, Bannon MJ, German DC. Low dopamine transporter mRNA levels in midbrain regions containing calbindin. Neuroreport. 5: 1641-4. PMID 7819538 DOI: 10.1097/00001756-199408150-00025 |
0.326 |
|
| 1993 |
Xia Y, Poosch MS, Whitty CJ, Kapatos G, Bannon MJ. GABA transporter mRNA: in vitro expression and quantitation in neonatal rat and postmortem human brain. Neurochemistry International. 22: 263-70. PMID 8443569 DOI: 10.1016/0197-0186(93)90054-9 |
0.585 |
|
| 1993 |
Lentz SI, Poosch MS, Hirayama K, Kapatos G, Bannon MJ. Substance P gene expression in sympathetic neurons is regulated by neuron/support cell interaction. Brain Research. Developmental Brain Research. 73: 35-40. PMID 7685666 DOI: 10.1016/0165-3806(93)90043-A |
0.356 |
|
| 1993 |
Whitty CJ, Kapatos G, Bannon MJ. Neurotrophic effects of substance P on hippocampal neurons in vitro. Neuroscience Letters. 164: 141-4. PMID 7512243 DOI: 10.1016/0304-3940(93)90877-N |
0.587 |
|
| 1992 |
Xia Y, Goebel DJ, Kapatos G, Bannon MJ. Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal. Journal of Neurochemistry. 59: 1179-82. PMID 1494906 DOI: 10.1111/J.1471-4159.1992.Tb08365.X |
0.472 |
|
| 1992 |
Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B, Kapatos G. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proceedings of the National Academy of Sciences of the United States of America. 89: 7095-9. PMID 1353885 DOI: 10.1073/Pnas.89.15.7095 |
0.465 |
|
| 1992 |
Bannon MJ, Poosch MS, Haverstick DM, Mandal A, Xue IC, Shibata K, Dragovic LJ. Preprotachykinin gene expression in the human basal ganglia: characterization of mRNAs and pre-mRNAs produced by alternate RNA splicing. Brain Research. Molecular Brain Research. 12: 225-31. PMID 1312203 DOI: 10.1016/0169-328X(92)90088-S |
0.327 |
|
| 1992 |
Bannon M, Whitty C, Goebel D, Poosch M. Localization of neurokinin receptor gene expression in the developing and adult rat brain Regulatory Peptides. 37: S189. DOI: 10.1016/0167-0115(92)91044-Z |
0.585 |
|
| 1991 |
Bannon MJ, Haverstick DM, Shibata K, Poosch MS. Preprotachykinin gene expression in the forebrain: regulation by dopamine. Annals of the New York Academy of Sciences. 632: 31-7. PMID 1952630 DOI: 10.1111/J.1749-6632.1991.Tb33091.X |
0.465 |
|
| 1991 |
Freeman AS, Chiodo LA, Lentz SI, Wade K, Bannon MJ. Release of cholecystokinin from rat midbrain slices and modulatory effect of D2DA receptor stimulation. Brain Research. 555: 281-7. PMID 1682000 DOI: 10.1016/0006-8993(91)90353-W |
0.389 |
|
| 1991 |
Wolf ME, LeWitt PA, Bannon MJ, Dragovic LJ, Kapatos G. Effect of aging on tyrosine hydroxylase protein content and the relative number of dopamine nerve terminals in human caudate. Journal of Neurochemistry. 56: 1191-200. PMID 1672141 DOI: 10.1111/J.1471-4159.1991.Tb11410.X |
0.558 |
|
| 1990 |
Haverstick DM, Jeziorski M, Bannon MJ. Developmental profile of striatal preprotachykinin gene expression. Journal of Neurochemistry. 55: 764-8. PMID 2384750 DOI: 10.1111/J.1471-4159.1990.Tb04557.X |
0.31 |
|
| 1990 |
Bannon MJ, Xue CH, Shibata K, Dragovic LJ, Kapatos G. Expression of a human cocaine-sensitive dopamine transporter in Xenopus laevis oocytes. Journal of Neurochemistry. 54: 706-8. PMID 2137162 DOI: 10.1111/J.1471-4159.1990.Tb01929.X |
0.476 |
|
| 1990 |
Shibata K, Haverstick DM, Bannon MJ. Tachykinin gene expression in rat limbic nuclei: modulation by dopamine antagonists. The Journal of Pharmacology and Experimental Therapeutics. 255: 388-92. PMID 1976801 |
0.348 |
|
| 1990 |
Helke CJ, Krause JE, Mantyh PW, Couture R, Bannon MJ. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 4: 1606-15. PMID 1969374 DOI: 10.1096/Fasebj.4.6.1969374 |
0.308 |
|
| 1989 |
Bannon MJ, Kelland M, Chiodo LA. Medial forebrain bundle stimulation or D-2 dopamine receptor activation increases preproenkephalin mRNA in rat striatum. Journal of Neurochemistry. 52: 859-62. PMID 2521894 DOI: 10.1111/J.1471-4159.1989.Tb02533.X |
0.447 |
|
| 1987 |
Bannon MJ, Elliott PJ, Bunney EB. Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists. Brain Research. 427: 31-7. PMID 2448008 DOI: 10.1016/0169-328X(87)90041-6 |
0.444 |
|
| 1986 |
Bannon MJ, Deutch AY, Tam SY, Zamir N, Eskay RL, Lee JM, Maggio JE, Roth RH. Mild footshock stress dissociates substance P from substance K and dynorphin from Met- and Leu-enkephalin. Brain Research. 381: 393-6. PMID 2428438 DOI: 10.1016/0006-8993(86)90097-1 |
0.677 |
|
| 1986 |
Lee JM, McLean S, Maggio JE, Zamir N, Roth RH, Eskay RL, Bannon MJ. The localization and characterization of substance P and substance K in striatonigral neurons. Brain Research. 371: 152-4. PMID 2423184 DOI: 10.1016/0006-8993(86)90820-6 |
0.471 |
|
| 1986 |
Bannon MJ, Lee JM, Giraud P, Young A, Affolter HU, Bonner TI. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. The Journal of Biological Chemistry. 261: 6640-2. PMID 2422168 |
0.307 |
|
| 1986 |
Elliott PJ, Alpert JE, Bannon MJ, Iversen SD. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area. Brain Research. 363: 145-7. PMID 2418910 DOI: 10.1016/0006-8993(86)90667-0 |
0.656 |
|
| 1985 |
Deutch AY, Maggio JE, Bannon MJ, Kalivas PW, Tam SY, Goldstein M, Roth RH. Substance K and substance P differentially modulate mesolimbic and mesocortical systems. Peptides. 6: 113-22. PMID 2417207 DOI: 10.1016/0196-9781(85)90143-3 |
0.688 |
|
| 1984 |
Chiodo LA, Bannon MJ, Grace AA, Roth RH, Bunney BS. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience. 12: 1-16. PMID 6462443 DOI: 10.1016/0306-4522(84)90133-7 |
0.596 |
|
| 1983 |
Bannon MJ, Wolf ME, Roth RH. Pharmacology of dopamine neurons innervating the prefrontal, cingulate and piriform cortices. European Journal of Pharmacology. 92: 119-25. PMID 6628534 DOI: 10.1016/0014-2999(83)90116-4 |
0.672 |
|
| 1983 |
Bannon MJ, Elliott PJ, Alpert JE, Goedert M, Iversen SD, Iversen LL. Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones. Nature. 306: 791-2. PMID 6197656 DOI: 10.1038/306791A0 |
0.663 |
|
| 1983 |
Bannon MJ, Roth RH. Pharmacology of mesocortical dopamine neurons. Pharmacological Reviews. 35: 53-68. PMID 6138783 |
0.509 |
|
| 1982 |
Reinhard JF, Bannon MJ, Roth RH. Acceleration by stress of dopamine synthesis and metabolism in prefrontal cortex: antagonism by diazepam. Naunyn-Schmiedeberg's Archives of Pharmacology. 318: 374-7. PMID 7078670 DOI: 10.1007/BF00501182 |
0.521 |
|
| 1982 |
Bannon MJ, Reinhard JF, Bunney EB, Roth RH. Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurones. Nature. 296: 444-6. PMID 7063040 DOI: 10.1038/296444a0 |
0.577 |
|
| 1982 |
Holcomb HH, Bannon MJ, Roth RH. Striatal dopamine autoreceptors uninfluenced by chronic administration of antidepressants. European Journal of Pharmacology. 82: 173-8. PMID 6813129 DOI: 10.1016/0014-2999(82)90507-6 |
0.541 |
|
| 1981 |
Michaud RL, Bannon MJ, Roth RH. The use of c8-octyl columns for the analysis of catecholamines by ion-pair reversed-phase liquid chromatography with amperometric detection. Journal of Chromatography. 225: 335-45. PMID 7298769 DOI: 10.1016/S0378-4347(00)80282-0 |
0.458 |
|
| 1981 |
Bannon MJ, Bunney EB, Roth RH. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems. Brain Research. 218: 376-82. PMID 7272743 |
0.52 |
|
| 1981 |
Bannon MJ, Michaud RL, Roth RH. Mesocortical dopamine neurons. Lack of autoreceptors modulating dopamine synthesis. Molecular Pharmacology. 19: 270-5. PMID 6785571 |
0.526 |
|
| 1981 |
Braszko JJ, Bannon MJ, Bunney BS, Roth RH. Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity. The Journal of Pharmacology and Experimental Therapeutics. 216: 289-93. PMID 6257886 |
0.494 |
|
| 1981 |
Zigun JR, Bannon MJ, Roth RH. Comparison of two alpha-noradrenergic agonists (clonidine and guanfacine) on norepinephrine turnover in the cortex of rats during morphine abstinence. European Journal of Pharmacology. 70: 565-70. PMID 6113150 DOI: 10.1016/0014-2999(81)90368-X |
0.479 |
|
| 1980 |
Bannon MJ, Jarboe CH, Carr LA, Duncan GE. Central nervous system actions of 2,5-bis(3,4-dimethoxybenzyl) cyclopentyl amine, a peripheral dopamine blocking agent. Life Sciences. 26: 225-29. PMID 7360005 DOI: 10.1016/0024-3205(80)90297-0 |
0.625 |
|
| 1980 |
Bannon MJ, Bunney EB, Zigun JR, Skirboll LR, Roth RH. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol. Naunyn-Schmiedeberg's Archives of Pharmacology. 312: 161-5. PMID 6772975 DOI: 10.1007/BF00569725 |
0.567 |
|
| 1980 |
Bannon MJ, Grace AA, Bunney BS, Roth RH. Evidence for an irreversible interaction of bromocryptine with central dopamine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 312: 37-41. PMID 6104795 DOI: 10.1007/BF00502572 |
0.577 |
|
| 1978 |
Bannon MJ, Jarboe CH. Reconsideration of a test for dopaminergic stimulation: inability of apomorphine to induce mouse jumping. Experientia. 34: 767-8. PMID 658298 DOI: 10.1007/BF01947314 |
0.596 |
|
| 1978 |
Jarboe CH, Lipson SF, Bannon MJ, Dunnigan DA. 2,5-Bis(3,4-dimethoxybenzyl)cyclopentylamine, a peripheral dopamine blocking agent. Journal of Medicinal Chemistry. 21: 1318-20. PMID 569208 |
0.639 |
|
| 1978 |
Jarboe CH, Bannon MJ, Lipson SF. Pharmacology of beta-(3,4-dimethoxyphenyl)ethyl amine: lack of peripheral and central antidopaminergic properties. The Journal of Pharmacy and Pharmacology. 30: 450-1. PMID 27614 |
0.532 |
|
| 1978 |
Bannon MJ, Jarboe CH. The behavioral pharmacology of 2,5-bis(3,4-dimethoxybenzyl) cyclopentyl amine HCl Federation Proceedings. 37: No. 3371. |
0.536 |
|
| Show low-probability matches. |
